New ways viruses affect human immune response discovered

August 3, 2012

(Medical Xpress) -- New ways that viruses manipulate the human immune response have been revealed in a research paper just published in Nature involving TCD scientists. Dr Orla Mulhern and Professor Andrew Bowie, School of Biochemistry and Immunology based in the Trinity Biomedical Sciences Institute were part of the multi-disciplinary, multi-centre study comprising immunologists, virologists, biochemists and bioinformaticians from across Europe.

This research is the most comprehensive study to date analysing strategies used by over 30 viruses to target defence networks in human cells, and provides many new insights into how viruses seek to avoid and weaken the immune response. The research findings could ultimately lead to the development of broad and specific antiviral therapies and new ways to treat patients with infectious diseases.

Scientists at the Centre for Molecular Medicine of the Austrian Academy of Sciences (CeMM) gathered 70 viral genes known to modulate the immune response from collaborators across Europe, including Trinity, and systematically inserted these genes into human cells. The genes were derived from 30 different viruses, including poxviruses, herpesviruses, and . They then used to identify all the human proteins targeted by the products of the inserted genes, and bioinformatics to comprehensively analyse the viral- interactions. Collaborating labs, including Trinity, then verified and validated some of the most exciting new viral-human interactions discovered. 

Commenting on the significance of the research, Professor Bowie, Head of Immunology, School of Biochemistry and Immunology, TCD stated: “The data shows that viruses target a much wider array of cellular processes than was previously anticipated. At least some of these cellular processes will have important but previously unrecognised anti-viral roles. Thus follow-on studies in our lab and others will reveal new anti-viral immune defences operating in human cells. Also since we could identify both common and unique targets for viruses in cells, future work will also help towards designing antiviral therapies both for specific viruses and for broad classes of viruses.”

Explore further: Big picture of how interferon-induced genes launch antiviral defenses revealed

More information: Pichlmair, A., Kandasamy, K., Alvisi, G., Mulhern, O., Sacco, R., Habjan, M., Binder, M., Stefanovic, A., Eberle, C., Goncalves, A., Bürckstümmer, T., Müller, A., Fauster, A., Holze, C., Lindsten, K., Goodbourn, S., Kochs, G., Weber, F., Bartenschlager, R., Bowie, A.G., Bennett, K.L., Colinge, J. & Superti-Furga, G. 2012. Viral immune modulators perturb the human molecular network by common and unique strategies. Nature 487, 486-490.

Related Stories

Big picture of how interferon-induced genes launch antiviral defenses revealed

April 10, 2011
When viruses attack, one molecule more than any other fights back. Interferon triggers the activation of more than 350 genes, and despite the obvious connection, the vast majority have never been tested for antiviral properties. ...

Recommended for you

Immune cells turn back time to achieve memory

December 13, 2017
Memory T cells earn their name by embodying the memory of the immune system - they help the body remember what infections or vaccines someone has been exposed to. But to become memory T cells, the cells go backwards in time, ...

Steroid study sheds light on long term side effects of medicines

December 13, 2017
Fresh insights into key hormones found in commonly prescribed medicines have been discovered, providing further understanding of the medicines' side effects.

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Researchers bring new insight into Chediak-Higashi syndrome, a devastating genetic disease

December 12, 2017
A team of researchers from the National Institutes of Health and University of Manchester have uncovered new insights into a rare genetic disease, with less than 500 cases of the disease on record, which devastates the lives ...

Drug increases speed, safety of treatment for multiple food allergies

December 11, 2017
In a randomized, controlled phase-2 clinical trial, an asthma medication increased the speed and safety of a protocol used to treat children for several food allergies at once, according to a study by researchers at the Stanford ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.